HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Survival in a large elderly population of patients with dementia and other forms of psychogeriatric diseases.

AbstractBACKGROUND:
Dementia and other psychogeriatric diseases in elderly patients bring an increased risk of death. Better knowledge of prognosis in elderly patients affected by dementia or mental illness should be of great importance in order to improve care plans and assist in medical decisions.
METHODS:
We have investigated the survival time in 2,112 patients with dementia and other forms of psychogeriatric diseases, enrolled during 1990 to 2005 and followed up until 2009, and the influence of diagnoses, plasma homocysteine level, presence of vascular disease and renal impairment.
RESULTS:
The survival time after diagnosis in most diagnostic groups is about a third compared to an average population of similar age and sex. Age was the main predictor of survival time in all patients.
CONCLUSIONS:
All diagnoses, except in patients with subjective cognitive impairments, showed an increased mortality. These estimates can be used for prognosis and planning for patients, carers, service providers and policy makers.
AuthorsKarin Nilsson, Lars Gustafson, Björn Hultberg
JournalDementia and geriatric cognitive disorders (Dement Geriatr Cogn Disord) Vol. 32 Issue 5 Pg. 342-50 ( 2011) ISSN: 1421-9824 [Electronic] Switzerland
PMID22311259 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 S. Karger AG, Basel.
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (mortality)
  • Cognitive Dysfunction (mortality)
  • Delirium (mortality)
  • Dementia (mortality)
  • Dementia, Vascular (mortality)
  • Depressive Disorder (mortality)
  • Female
  • Humans
  • Male
  • Mental Disorders (mortality)
  • Middle Aged
  • Survival Rate
  • Sweden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: